Rocket Pharmaceuticals Presents Clinical Data from RP-A501 Trial in Danon Disease

  • Jonathan Schwartz,

Press/Media

Period23 Sep 2021

Media coverage

1

Media coverage

  • TitleRocket Pharmaceuticals Presents Clinical Data from RP-A501 Trial in Danon Disease
    Media name/outletManufacturing Close-Up
    Country/TerritoryUnited States
    Date23/09/21
    PersonsJonathan Schwartz,
View all 1
View less